Compare KZIA & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KZIA | RAIL |
|---|---|---|
| Founded | 1994 | 1901 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 141.0M |
| IPO Year | 2002 | 2005 |
| Metric | KZIA | RAIL |
|---|---|---|
| Price | $5.61 | $4.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $28.76 | $10.67 |
| AVG Volume (30 Days) | 167.6K | ★ 422.5K |
| Earning Date | 11-27-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 134.94 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $500,991,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $48.30 |
| P/E Ratio | ★ N/A | $15.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.86 | $3.85 |
| 52 Week High | $17.40 | $14.90 |
| Indicator | KZIA | RAIL |
|---|---|---|
| Relative Strength Index (RSI) | 26.35 | 42.06 |
| Support Level | $4.86 | $3.94 |
| Resistance Level | $14.85 | $7.55 |
| Average True Range (ATR) | 0.68 | 0.31 |
| MACD | -0.10 | 0.16 |
| Stochastic Oscillator | 2.75 | 39.52 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.